Form 13-F position report

ADARX PHARMACEUTICALS INC

Reported by EcoR1 Capital LLC

ADRX CUSIP 00654F105 Manager CIK 0001587114

First reported at 1,150,000 shares this quarter.

New
% of reported 13F value 1.02% This manager · Q3 2026
Shares 1,150,000 Quarter-end amount reported
Reported value $22,931,000 Fair value at quarter end
Consecutive quarters held 1 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2026-09-30 22931000

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for ADARX PHARMACEUTICALS INC held by EcoR1 Capital LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 New 1,150,000 +1,150,000 (0.0%) 1.02% $22,931,000 2026-11-16

Who else reported the position

62 managers reported ADARX PHARMACEUTICALS INC for Q3 2026.

Managers reporting ADARX PHARMACEUTICALS INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
ORBIMED ADVISORS LLC New 24,205,789 +24,205,789 8.81% $482,663,433 1 qtr
SR ONE CAPITAL MANAGEMENT LP New 9,936,661 +9,936,661 17.24% $198,137,020 1 qtr
Bain Capital Life Sciences Investors LLC New 6,728,970 +6,728,970 9.01% $134,175,662 1 qtr
TCG Crossover Management LLC New 4,116,452 +4,116,452 2.32% $82,082,053 1 qtr
FMR LLC New 3,646,090 +3,646,090 < 0.01% $72,703,035 1 qtr
PRICE T ROWE ASSOCIATES INC MD New 2,894,396 +2,894,396 < 0.01% $57,715,000 1 qtr
BlackRock Inc New 2,336,110 +2,336,110 < 0.01% $46,582,032 1 qtr
Capital International Investors New 2,132,301 +2,132,301 < 0.01% $42,518,082 1 qtr
Siren L L C New 1,925,794 +1,925,794 0.91% $38,400,332 1 qtr
ALLIANCEBERNSTEIN L P New 1,719,816 +1,719,816 0.01% $34,293,131 1 qtr
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM ADDED

Voting authority reported

Sole
1,150,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.